News | December 19, 2025
Lupin signs exclusive licensing pact with Neopharmed for Plasil in Philippines and Brazil
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The state-of-the-art facility is expected to be commissioned over the next three years
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
Patients with BRCA mutations often face aggressive disease and poor prognosis
The company shall process the change of name application with BSE Ltd. in due course
India plays a critical role in Bristol Myers Squibb’s global strategy
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
Subscribe To Our Newsletter & Stay Updated
